Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase

HA Berman and K Leonard

Department of Biochemical Pharmacology, State University of New York, Buffalo 14260.

This paper examines inhibition of acetylcholinesterase (AchE) and butyrylcholinesterase (BuchE) by tetrahydroaminoacridine (THA), an acridine analog under consideration for palliative treatment of Alzheimer's dementia. THA causes linear mixed inhibition of AchE hydrolysis of acetylthiocholine, a cationic substrate (KI = 3.8 x 10(- 9) M), and linear competitive inhibition of AchE hydrolysis of 7- acetoxy-4-methylcoumarin, an uncharged substrate (KI = 6.8 x 10(-9) M), and N-methyl-7-dimethylcarbamoxyquinolinium, a cationic carbamate (KI = 1.5 x 10(-8) M). Propidium association with AchE in the presence of saturating concentrations of THA is characterized by a dissociation constant of 7.7 +/- 0.7 x 10(-6) M, a value within 2-fold of the dissociation constant in the absence of THA. Association of THA with AchE is, therefore, not mutually exclusive with association of propidium at the peripheral anionic site. Moreover, THA causes dissociation of decidium complexes with AchE at concentrations compatible with a dissociation constant of 7.0 +/- 0.4 x 10(-9) M. Similar relationships were observed for THA inhibition of BuchE hydrolysis of butyrylthiocholine (KI = 2.5 x 10(-8) M) and dissociation of decidium complexes with BuchE (KD = 1.9 +/- 0.1 x 10(-8) M). These kinetic and equilibrium data uniformly indicate that THA associates with AchE and BuchE with high affinity and that the subsequent inhibition comes about through ligand association at the active center rather than at a peripheral site. The noncompetitive component of inhibition reflects association of THA with the acyl-enzyme intermediate, with subsequent effects on the rate of deacylation.

Volume 41, Issue 2, pp. 412-418, 02/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				A. A. Kousba, L. G. Sultatos, T. S. Poet, and C. Timchalk Comparison of Chlorpyrifos-Oxon and Paraoxon Acetylcholinesterase Inhibition Dynamics: Potential Role of a Peripheral Binding Site Toxicol. Sci., August 1, 2004; 80(2): 239 - 248. [Abstract] [Full Text] [PDF]

				H. M. Dodds and L. P. Rivory The Mechanism for the Inhibition of Acetylcholinesterases by Irinotecan (CPT-11) Mol. Pharmacol., December 1, 1999; 56(6): 1346 - 1353. [Abstract] [Full Text]

				Y.-P. Pang, P. Quiram, T. Jelacic, F. Hong, and S. Brimijoin Highly Potent, Selective, and Low Cost Bis-tetrahydroaminacrine Inhibitors of Acetylcholinesterase. STEPS TOWARD NOVEL DRUGS FOR TREATING ALZHEIMER'S DISEASE J. Biol. Chem., September 27, 1996; 271(39): 23646 - 23649. [Abstract] [Full Text] [PDF]